drugset / Trial / NCT03388463

Single Dose Omeprazole Versus High Dose in High-risk Critically Ill Patients.

NCT03388463

Completed 110 enrolled Menoufia University
RandomizedCrossoverQuadruple-blindPrevention

Summary

Upper gastrointestinal (GIT) bleeding is common in high risk critically ill patients. Hyperacidity has been identified as one of the main reasons for bleeding.1 2 Antacids with different treatment modalities have been studied to establish the best regimen for prophylaxis against bleeding.3 4 Proton pump inhibitors (PPI) are the most common drugs used in the medical field as antacids. The present study was carried out to investigate the beneficial effects of high dose omeprazole versus standard low dose as a prophylaxis against upper GIT bleeding in high risk critically ill patients.

Timeline

Start
2016-05-11
Primary completion
2017-08-14
Completion
2017-09-17

Drugs

EvaluationDrugModalityDoseRoute
Comparator Omeprazole Other / unclassified 8 mg Intravenous

Indications

No indication recorded.